Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Peptide Ruling Stalls

Pharmaceutical Executive Daily: Peptide Ruling Stalls

Published 1 month, 2 weeks ago
Description
Novo Nordisk data show real-world weight loss after switching to its oral semaglutide pill, FDA's peptide rulemaking stalls while its enforcement arm targets compounded peptide sellers, and Avi Pardo flags a compliance blind spot in field teams' text messages with doctors.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us